Pharmaceutical Formulation of Lead Drug Candidates
$334,667N01FY2012AGNIH
Murty Pharmaceuticals, Inc., Lexington KY
Investigators
Abstract
Task Order 3 Purpose: Preparation of Intravenous formulations of (R,R)-4'-Methoxy-1- Naphthylfenoterol (MNF)
View original record on NIH RePORTER →